The Max Planck Institute of Psychiatry (MPI-P) is one of 86 research institutes of the Max Planck Society for the Advancement of Science (MPS), Germany’s research organization for basic research. Since its establishment in 1948, the MPS has been home to 18 Nobel laureates. MPI-P was founded in 1917. Today, it focuses on interaction between basic science, clinical research and clinical services in order to gain knowledge about and understanding of the causes of psychiatric disorders, such as depression and anxiety disorders. This knowledge can then be applied in the development of novel diagnostic possibilities as well as therapeutic and preventive approaches. Stress-related disorders, such as major depression and anxiety disorders are the main research and clinical focus.
MPI-P basic research focuses on translational research in Psychiatry and stress neurobiology and neurogenetics. The research departments are closely interlinked with the hospital, which incorporates a 120-bed hospital, numerous outpatient clinics and three day clinics.